NOCIL194.49

NOCIL Limited

· Chemicals
₹ CrorePeersHSCLROSSARINAVINFLUORDDEVPLSTIKTATACHEMCHEMPLASTSAARTIINDJGCHEMMcap ₹3,248 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth-3.6-6.4
EBITDA Growth-29.5-26.7
EBIT Growth-41.1-45.2
Net Income Growth-22.7-45.9
EPS Growth-22.7-46.0
Total Assets Growth+2.1+2.6
Total Equity Growth+3.7+0.6
Cash from Operations Growth-87.3+886.2
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.